Item 8.01 Other Events
As previously reported, on
On
CytoDyn further announced that intends to continue studying leronlimab in other
HIV-related indications, which
2
© Edgar Online, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -98.31% | -.--% | -98.31% |
2023 | Regnum Corp. Announces Resignation of Anne Kirby as Chief Executive Officer | CI |
2023 | Regnum Corp. Announces Resignation of Anne Kirby as Sole Member of Board of Directors | CI |
Item 8.01 Other Events
As previously reported, on
On
CytoDyn further announced that intends to continue studying leronlimab in other
HIV-related indications, which
2
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
-98.31% | 2.3K | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |